Our Team
Managing Directors
Co-founder
Head of Division of Structural Biology of Infection and Immunity, German Cancer Research Center. Former Head of the Laboratory of Structural Microbiology at the Rockefeller University. Expertise in protein biochemistry, X-ray crystallography, and microbial pathogenesis.
Co-founder
Head of Division of Immune Diversity, German Cancer Research Center and Professor at Heidelberg University. Former Head of the Laboratory of Lymphocyte Biology for at the Rockefeller University Expertise in immunology, RNA modifications, and parasitology.
Management
Co-founder, CSO
With a PhD from the City University of New York, Dr. Verdi specializes in biochemistry and infection biology with a strong background in trypanosomiasis. He is the principle investigator for an NIH SBIR award to VAST-sublicensee Hepione Therapeutics Inc.
Co-founder, COO
Expert in immunotherapy and vaccine development. Trained in business administration with experience as a consultant for pharma companies. Received his PhD from the University of Heidelberg and the German Cancer Research Center (DKFZ).
Advisory Board Member
Director Innovation Management at DKFZ German Cancer Research Center, Founder & Managing Partner MIM Deutschland GmbH, former CEO Ganymed Pharmaceuticals
Advisory Board Member, Co-founder
Experienced analyst of 30+ years on Wall Street with extensive expertise in fundraising for small biotech companies.
Personnel
-
Monica Chandra, PhD
Senior Scientist
-
Anastasia Gkeka, PhD
Senior Scientist
-
Nataliia Kashpur, PhD
Scientist
-
Eblina Kelmendi, BSc
Technical Assistant
-
Seneca Kinn-Gurzo, BA
Scientist
-
Jose Paulo Lorenzo, PhD
Senior Scientist
-
Colin Miller, PhD
Postdoctoral Fellow
-
Eleftheria Papamanoglou, MSc
Biochemistry Assistant
-
Tim Pufall, Dipl. Übersetzer
Administrative Assistant
-
Sandra Ruf, MSc
Scientist
-
Dimitra Stamkopoulou, MSc
Scientist
-
Katharina Urban, PhD
Senior Scientist
-
Evi Vlachou, MSc, MSc
Bioinformatics Consultant